Caixin
Jan 25, 2018 06:14 PM
M&A

Chinese Medical Firm Eyes Johnson & Johnson Diabetes Unit

Johnson & Johnson’s diabetes business has been in decline since 2011. Revenue dropped 32% to $1.8 billion in 2016 from five years earlier. Photo: VCG
Johnson & Johnson’s diabetes business has been in decline since 2011. Revenue dropped 32% to $1.8 billion in 2016 from five years earlier. Photo: VCG

Chinese medical test-developer Sinocare Inc. has confirmed its interest in potentially acquiring Johnson & Johnson’s diabetes care unit.

The Shenzhen-listed company — which makes blood sugar monitoring systems — said it has hired agencies to study a possible deal, but that there was no timeline and talks could be halted at any time.

The deal could fetch up to $4 billion, Reuters reported earlier this month, citing unnamed sources with direct knowledge of the discussions.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
GALLERY
Copyright © 2017 Caixin Global Limited. All Rights Reserved.